Literature DB >> 15083772

Conceptual issues in measuring the burden of skin diseases.

Mary-Margaret Chren, Martin A Weinstock.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15083772     DOI： 10.1111/j.1087-0024.2004.09119.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN： 1087-0024


× No keyword cloud information.
  6 in total

Review 1.  [The educational program for the management of psoriasis vulgaris according to the rules of the Task Force on Dermatological Prevention: current status].

Authors:  T Werfel; E Breitbart; A Kleinheinz; U Gieler; G Schmid-Ott
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

2.  [Psychosocial consequences of psoriasis--an empirical study of disease burden in 3753 affected people].

Authors:  G Schmid-Ott; P Malewski; I Kreiselmaier; U Mrowietz
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

3.  A Method for Designing a Patient Burden Questionnaire in Dermatology.

Authors:  Khaled Ezzedine; Mohammed Bennani; Jason Shourick; Charles Taieb
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-08-06

4.  Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis.

Authors:  Zehui He; Chuanjian Lu; Aihua Ou; Jiqian Fang; Dongmei Wang; Jingwen Deng; Zhongzhao Zhang; Jingjie Yu
Journal:  Health Qual Life Outcomes       Date:  2012-04-13       Impact factor: 3.186

5.  Burden of albinism: development and validation of a burden assessment tool.

Authors:  Fanny Morice-Picard; Charles Taïeb; Aurelie Marti; Antoine Gliksohn; Mohammed Bennani; Christine Bodemer; Khaled Ezzedine
Journal:  Orphanet J Rare Dis       Date:  2018-09-18       Impact factor: 4.123

6.  Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.

Authors:  Marie-Laure Armand; Charles Taieb; Aline Bourgeois; Mireille Bourlier; Mohammed Bennani; Christine Bodemer; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.